The Challenge
Shire retained PharmaBioSource Realty as its exclusive real estate broker to divest the assets in its 58,000-square-foot mammalian cell culture drug substance pilot plant facility near San Francisco, California. The facility housed multiple 1,000L and 2,000L bioreactors.
The Solution
PharmaBioSource Realty marketed the assets and lease assumption to strategic acquirers.
Services provided by the PharmaBioSource Realty team:
- Benchmark valuation
- Buyer target identification and engagement
- Creation of the Confidential Information Memorandum (CIM)
- Data room development
- Due diligence support
- Negotiations and closing support
The Results
PharmaBioSource Realty identified Lonza, a global CDMO, as the acquirer. Lonza acquired the assets and assumed the lease for the facility to expand its development and clinical-scale manufacturing presence in the United States.
What We Did
Real Estate Brokerage
Facility Divestiture